Biodegradable drug delivery vascular stent
January 13, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPlastic molded articles with shape memory property Microporous vascular graft Peptides with laminin activity Endovascular stent and delivery system Nitinol stent for hollow body conduits Vascular prosthesis containing in the wall microcapsules, including hormone-producing cells Impregnated stent Resorbable vascular wound dressings Patent #: 5376376 InventorsApplicationNo. 372822 filed on 01/13/1995US Classes:623/1.22, Helically wound604/104, Having means expanding body orifice or canal (e.g., dilator, retaining means, etc.)606/154, Bioabsorbable606/194, Inserted in vascular system623/1.38, Absorbable in natural tissue623/1.42Drug deliveryExaminersPrimary: Prebilic, Paul B.Attorney, Agent or FirmInternational ClassA61F 002/06AbstractA stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs. | |
